GlassScriptPhysician profile
Michael Nissan
NPI 1710515234
$2,221.76
in general payments reported to CMS, 2019-2025
11 companies · $661 in 2025
The $661 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $287 · 2023: $199 · 2024: $1,075 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $824.10 | 2023-2024 | |
| Axogen | $290.80 | 2025 | |
| Depuy Synthes Sales INC. | $262.70 | 2024 | Trumatch, Matrixmandible |
| Revance Therapeutics, INC. | $145.09 | 2025 | Daxxify |
| Stryker Corporation | $142.16 | 2022-2023 | Spy-Phi System |
| Allergan, INC. | $122.79 | 2022 | |
| Motiva USA, LLC | $118.39 | 2025 | |
| Polynovo North America LLC | $107.06 | 2025 | Novosorb Btm |
| Bausch & Lomb Americas INC. | $94.60 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $80.03 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $34.04 | 2022-2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nissan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.